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Abstract The increase in allergic diseases over the past several decades is correlated with
changes in the composition and diversity of the intestinal microbiota. Microbial-derived signals
are critical for instructing the developing immune system and conversely, immune regulation
can impact the microbiota. Perturbations in the microbiota composition may be especially
important during early-life when the immune system is still developing, resulting in a critical
window of opportunity for instructing the immune system. This review highlights recent studies
investigating the role of the microbiome in susceptibility or development of allergic diseases
with a focus on animal models that provide insight into the mechanisms and pathways involved.
Identification of a causal link between reduced microbial diversity or altered microbial
composition and increased susceptibility to immune-mediated diseases will hopefully pave the
way for better preventive therapies.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ch (K.D. McCoy).
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171Impact of the microbiota in allergic disease1. Introduction
The intestinal microbiota is the major component of the
host-microbial superorganism when one considers the num-
ber of cells, genes and metabolic capacity that it contributes
to the superorganism. Although the density and complexity
of the microbiota are highest in the lower intestine, all
mucosal surfaces, such as the skin, the oral cavity and the
lung, harbor a resident microbiota. The microbiota of each
body site has its own microbial profile and diversity index.
Many studies have linked disturbances (or dysbiosis) of the
microbiota to the development or progression of diseases.
Diseases that appear to be impacted by alterations in the
microbiota or linked to dysbiosis include metabolic diseases,
autoimmunity, inflammatory diseases, neurological diseases,
and allergy (reviewed in [1]). Of note, studies linking the
microbiome to allergic diseases have increased over the past
years and new data supporting a causal link between low
diversity microbiota and development of allergy is emerging.
Already in the late eighties the British physician David Strachan
proposed what is now referred to as the ‘hygiene-hypothesis’
[2]. Since then a steady increase in the occurrence of asthmatic
and allergic diseases, such as food allergy, has been reported in
industrialized countries [3]. Several environmental factors have
been implicated, including decreased exposure to commensal
microbes and infections, wide usage of antibiotics, water
decontamination, a continuous cold-chain delivery and food
pasteurization, all of which have become standard in developed
countries.
The evidence for the dependence of disease development
and changes in the microbiota is often deduced from clinical
correlative studies in the human population. One approach of
such studies is to monitor the intestinal microbial composition
during active disease and/or during periods of remission and
then evaluate whether active disease could be the cause or
consequence of changes in microbial composition, or converse-
ly, whether changes in the microbiota pave the way for disease
development or relapse. Other studies analyze the composition
of the intestinal microbiota following birth and throughout
infancy and retrospectively drawing conclusions from allergy
or asthma development during childhood. These studies have
provided evidence that allergic diseases correlate with changes
in the microbiota [4–8]. However, it is difficult to gain
mechanistic insight into how bacteria can shape an allergic
immune response from correlative studies. In this review we
will summarize recent publications that analyze mechanisms
and pathways that play a role in allergic or asthmatic diseases.
We will describe what is known regarding development of the
microbiota after birth and illustrate recent studies that have
started to provide mechanistic understanding into how the
microbiota impacts on development of allergic diseases. We
provide evidence for a critical window of microbiota develop-
ment that marks a crucial time in which we can profit from
adequate microbial-mediated immune stimulation and high-
light new studies investigating the role of the lungmicrobiome.
2. Intestinal microbiota
During the first three years of life our intestinal microbiota
establishes an adult-like microbial community that we largely
maintain for the rest of our lives [9,10]. After birth thenewborn intestine is an aerobic environment that allows
inhabitation of facultative anaerobes like Enterobacteriaceae.
Within a few days the lumen becomes anaerobic, thus allowing
other obligate anaerobic species, for example Bifidobacteria,
Clostridium spp. and Bacteroidetes, to populate the intestine.
It is now accepted that this initial colonization is heavily
influenced by the mode of delivery [11]. The microbiota of
children born with cesarean section (resembling the skin
microbiota) largely differs from children born vaginally (vaginal
microbiota) [11]. Delivery via cesarean section correlates with
delayed colonization with Bacteroidetes, a lower abundance
of Bifidobacteria and Bacteroidetes, and an overall lower
bacterial complexity even at one year of age [12]. Correlation
studies suggest that cesarean-born children are more likely
to develop obesity [13] inflammatory bowel disease (IBD) [14],
or asthma or atopic diseases [15] (critically reviewed in [16])
before adulthood. During the first month of life breast or
formula feeding also impacts composition of the human
gut microbiota [17]. The introduction of solid food then
leads to drastic shifts in composition and complexity of the
intestinal microbiota. The presence of new substrates in
the intestine, such as non-digestible carbohydrates, causes
a shift of the microbial community to incorporate those
species that can utilize and survive on the available energy
sources. For example, relative proportions of Bifidobacteria or
Enterobacteria decrease while relative proportions of some
Clostridia species increase their relative abundance [18]. With
these changes microbial composition and diversity become
more ‘adult-like’, and also more stable (Fig. 1). The adult
microbiota is represented by two main phyla: Firmicutes
and Bacteroidetes. Firmicutes comprise mainly the genera
Clostridium, Faecalibacterium, Blautia, Ruminococcus, and
Lactobacillus while Bacteroidetes are mainly represented by
Bacteroides and Prevotella. Less abundant are other phyla
such as Actinobacteria (Bifidobacteria) or Proteobacteria
(Enterobacteriaceae).
Although the gut microbiota is relatively stable in healthy
adults, it is influenced by a variety of environmental factors,
such as antibiotic use and the diet. It is probably not surprising
that the food we consume and the relative amounts of fat, fiber
or sugar play a profound role in shaping our microbiome and
thereby influencing our immune system. The interplay between
diet, microbiota, and the immune system is illustrated in Fig. 2.
Dietary metabolites are small molecules that are derived from
the food. They can be divided into microbiota-independent
metabolites, such as aryl-hydrocarbon receptor ligands, reti-
noid acid, or folic acid or microbiota-dependent metabolites
such as short-chain fatty acids (SCFAs), vitamin K or bile acids.
The receptors for dietary or bacterial metabolites are widely
expressed in our immune system and are particularly abundant
on innate cells like macrophages or innate lymphoid cells. The
interplay between the diet, metabolites and inflammation has
been the subject of a recent comprehensive review [19] and
therefore will not be discussed in detail here.
Recently, it was proposed to classify every human
microbiome into one of three “enterotypes” [20] but until
now no agreement on a “normal” or healthy microbiota has
been made. Currently the ratio between the Firmicutes and
Bacteroides abundances and the overall diversity of the
microbiota seem to be most predictive of any correlation of
themicrobiomewith a variety of diseases and is widely used as
a read-out.
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Figure 1 Microbial colonization dynamics. Diversity of the intestinal microbiota increases with age and is influenced by key life
events including mode of delivery, antibiotic use, introduction of solid food, and health of the individual. Reduced microbial diversity
early in life is correlated with increased risk for development of diseases.
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Figure 2 Interplay between diet, xenobiotics, microbiota
and the immune system. The immune system is influenced by
all three external factors, which also heavily impact on each
other.
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It is only recently that the existence of a lung microbiome has
been appreciated and first publications have aimed to find a
correlation between lung disease and the lung microbiota in
humans [21] and in mice [22]. Much like the intestinal
microbiota, the lung microbiota develops after birth with
successive population of the tissue with bacterial species. The
neonatal lung microbiome almost exclusively consists of
Firmicutes and Gammaproteobacteria, while Bacteroidetes
slowly expand with age until they exceed the number of
Firmicutes in adults [22]. A ratio between Bacteroidetes
and Firmicutes that is shifted towards Firmicutes, and thus an
immature, neonatal-like microbiota, may be a predictive
marker for susceptibility to asthma and development of
allergies.
4. Virome
The intestinal and lung ecological habitat is not only colonized
by bacteria. Notably non-bacterial organisms, particularly
viruses (mainly bacteriophages but also viruses that infect host
cells) and commensal fungi, are also found in this habitat and
comprise the commensal virome and mycobiome, respective-
ly. Bacteriophages are the main component of the virome.
173Impact of the microbiota in allergic diseaseHowever, in a healthy adult intestine most bacteriophages are
in the lysogenic cycle [23],meaning they are integrated into the
bacterial chromosome and the bacterium can continue to live
and replicate normally, which is in contrast to the lytic cycle
where the phage would kill the cell to generate progeny. The
composition of the non-bacterial members of themicrobiome is
probably as diverse as the bacterial community and is likely to
contribute to tissue homeostasis and disease pathogenesis. Very
little of the virome sequences are defined and the lack of
detailed databases and biological information makes it difficult
to assign any particular biological activity to the detected
sequences. It has been suggested that viruses are the most
abundant entity in the biosphere (including the ocean) with an
estimated number of 1031 [24]. A fundamental characteristic of
the non-bacterial community is that the mutation rate is very
high and the gene pool is large and diverse giving it a powerful
potential to affect neighboring communities. Further studies in
this emerging field may reveal a role for bacteriophages in
shaping the gut microbiota and any potential contribution to
disease [25–27].
Of particular note is the recent demonstration that an
enteric virus that can infect host cells, specifically murine
norovirus (MNV), can (at least partially) replace the beneficial
effects of the intestinal microbiota on immune system in mice
[28]. MNV is a commensal member of the mouse virome and
non-pathogenic in immune sufficient animals. Administration of
three strains of MNV as representatives of the mouse virome to
germ-free animals could restore many features of the intestinal
immune system that are attributed to bacteria, including
restoration of numbers and cytokine profiles of T cells or innate
lymphoid cell populations in the intestine, villus thickness and
Paneth cell granularity. Future studies should provide informa-
tion on the impact of the virome on susceptibility to allergic
diseases.5. The early life ‘window of opportunity’
The instability of the microbiota early in life clearly marks the
most sensitive time for detrimental insults to the bacterial
community. The emerging picture is that alterations that
occur while the community is being established have profound
and non-repairable consequences for the microbiome and
subsequently for immunity. In a landmark study, Olszak et al.
demonstrated that invariant natural killer T (iNKT) cells are
increased in number and frequency in the colonic lamina
propria and the lungs of germ-free animals [29]. A decrease in
iNKT cell numbers could only be restored if mice were
colonized with microbes in the first two weeks of life, but
not as adults. Early life microbial exposure was important to
ameliorate intestinal inflammation and development of
allergic asthma following antigen challenge. Increased ex-
pression of Cxcl16 was associated with the increase in iNKT
cells and subsequent disease susceptibility, and this effect was
microbial-dependent but independent of TLR adaptor protein
MyD88 and likely involved epigenetic imprinting [29].
We have also described an early life “window of
opportunity” whereby colonization with a diverse microbi-
ota was required to mediate appropriate immune regulation
[30]. In this study we investigated mechanisms involved in
the elevated IgE in germ-free (which we also refer to as
“hygiene-mediated IgE”) mice with the aim to understandhow commensal microbes can limit IgE induction and
mediate immune regulation. We found that serum IgE levels
started to increase in germ-free mice early in life, around
3–4 weeks of age correlating with the time of weaning.
Mechanistically, B cell class switch recombination to IgE
occurred in the Peyer's patches and mesenteric lymph
nodes, required IL-4 and was T cell-dependent, although
MHC Class II expression on B cells was not required. In
agreement with the findings of Olszak, we also found that
colonization with a diverse microbiota during adulthood
was not sufficient to mediate immune regulation and limit
IgE induction whereas colonization of neonates was protec-
tive. Furthermore, we found that colonization with one
(Escherichia coli) or two (Parabacteroides distasonis and
Lactobacillus murinus) bacterial species, even early in life,
was insufficient to limit IgE induction. In contrast, gnoto-
biotic mice needed to develop a diverse microbiota early
in life, within this ‘window of opportunity’ in order for
microbial-derived signals to mediate life-long immune regu-
lation. In addition to limiting hygiene-mediated IgE, diverse
colonization was also required to decrease susceptibility to
oral antigen-induced systemic anaphylaxis [30].
Maturation of the immune system that occurs pre- and
post-natally is a very important step in life and it necessitates
adaptation to the environment with the possibility to respond
to and tolerate surrounding antigens and toxins. These studies
support the concept that an early microbial education of the
immune system is required to establish a baseline immune
regulation for life. Perturbations of microbial communities
early in life are therefore likely to impact development of
allergic disease. In support of this, administration of vanco-
mycin, but not streptomycin, severely decreased diversity of
intestinal microbiota and administration of vancomycin in
neonates, but not adults, increased the severity of inflamma-
tion in a murine model of experimentally induced allergic
asthma and decreased the numbers of intestinal Treg [31].
A similar time window after birth in which immune
tolerance or responsiveness is established was also observed
in the lung, where the commensal lung microbiota could
prevent an exaggerated responsiveness to an aeroallergen only
after it had shifted its composition to a greater abundance
of Bacteroidetes [22]. Causal for the severe airway reaction
in neonates was a reduced PD-L1 expression on DC, which
resulted in a lack of Helios negative Treg cells indicating the
potential lack of induction of adaptive Treg.
6. Impact of intestinal microbiota on
allergic disease
Recent studies using animal models have provided some
mechanistic details suggesting a causal link between alter-
ations in the microbiota and disease, as suggested by the
human correlative studies. Complete absence of the microbi-
ota has a clear impact on immunity, as illustrated by studies in
germ-free mice. Indeed, it has long been know that germ-free
animals develop elevated levels of total serum IgE [32,33], a
hallmark of allergy and atopy. Using a model of allergic airway
inflammation, Herbst et al. demonstrated that germ-free
mice develop exaggerated airway inflammation compared
to mice colonized with a diverse microbiota [34]. Marked
reduction in the intestinal microbiota through oral antibiotic
174 K.D. McCoy, Y. Kölleradministration also led to increased serum IgE levels and
exaggerated allergic inflammation [35]. Elevated IgE corre-
lated with increased numbers of circulating basophils and
microbial-derived signals were required to limit IgE induction
and proliferation of bone marrow precursor populations [35].
Microbial control of basophil numbers may be of particular
importance in light of a recent study demonstrating that IL-4
secreted from basophils controlled the function of lung
natural helper cells and enhanced expression of CCL11, IL-5,
IL-9 and IL-13 in a murine model of allergen-induced airway
inflammation [36].
The complex network between dietary fiber, intestinal
microbiota and an allergic lung reaction was recently illustrat-
ed by Trompette et al. [37]. Feeding mice with a diet high
in fiber led to an increase in the relative abundance of
Bacteroidaceae and Bifidobacteriaceae and subsequently in-
creased systemically circulating levels of SCFA. The availability
of higher systemic SCFA stimulated DC hematopoiesis in the
bone marrow, which was ultimately associated with a less
pronounced allergic lung reaction to house dust mite. In this
allergic mouse model reduced eosinophil infiltration, a less
activated phenotype of CD11bhigh DC and an impaired Th2
response were also observed in mice administered with the
SCFA propionate. Surprisingly, the protective process required
the SCFA receptor GPR41 and not GPR43, which has previously
been reported to be crucial in mediating protective anti-
inflammatory effects in models of colitis or arthritis [38]. A
critical aspect of this publication is that it describes the chain
of events from dietary fiber to systemic metabolites to bone
marrow hematopoiesis ultimately leading to immune modula-
tion in the lung.7. Microbiota effects on oral tolerance and
food allergy
There are conflicting reports on the ability of germ-free
mice to respond to oral tolerance induction protocols
[39–41]. Nevertheless, the key role of intestinal bacteria in
the induction of Treg [42–46] and their role in oral tolerance
to food (reviewed in [47]) suggest that the microbiota is
implicated in the susceptibility to development of food
allergy [48].
Oral tolerance to ingested dietary antigens is classically
mediated by sampling of luminal antigens from DCs and
subsequent migration of CD103+ DC with priming of naïve T
cells in the mesenteric lymph nodes to become Treg [47].
Recent data suggests that this pathway is supported by the
presence of the commensal microbiota [49]. This study
demonstrated that macrophage-derived IL-1β is necessary
for RORγt+ innate lymphoid cells to secrete GM-CSF, a
colony-stimulating factor that influences the proliferation,
differentiation, function and survival of myeloid cells. Type
3 innate lymphoid cells (ILC3) were shown to be the main
source of GM-CSF in the intestine, which was important to
prime dendritic cells and macrophages to induce Treg. In
a model of oral tolerance to ovalbumin (OVA) reduced
numbers of OVA-specific Treg were induced when mice
were deficient in ILC-derived GM-CSF. This study elegantly
demonstrates the impact of commensal microbes on the
network of the innate immune system with consequences onadaptive immunity, although this study did not directly look
at effects on food allergy.
It had previously been shown that mice that were unable to
signal through TLR4 were highly susceptible to induction of
food allergy [50], leading to the speculation that responses
to LPS derived from the commensal microbiota dampened
allergic responses to food. Indeed, neonatal administration of
antibiotics also heightened the food allergy responses [50].
Mechanistic insight into the impact of intestinal microbiota
on sensitization to food antigens has recently been provided
by Stefka et al. [51]. The allergy-protective effects of the
microbiota were found to be derived from Clostridia spp.
present in the microbiota. Gnotobiotic mice that were
colonized with a microbiota containing Clostridia, but not
germ-free or Bacteroides uniformis monoassociated mice
induced an antibacterial response that was characterized by
an increase in IL-22 production from innate lymphoid cells and
a higher production of antimicrobial peptides such as RegIIIβ
and RegIIIγ. Clostridia-induced induction of IL-22 within the
intestinal mucosa led to reduced intestinal antigen uptake
after peanut sensitization and as a consequence, reduced
concentrations of food allergens in the systemic circulation, a
strong reduction in total and peanut-specific IgE levels, and a
less severe hypothermic response. In addition, the pool of
Treg cells was increased and intestinal IgA levels were
higher in mice with the Clostridia-containing microbiota, but
this adaptive response was independent of IL-22 induction.
Instead, it seems likely that bacterial metabolites like SCFAs
that are known to be produced by Clostridia spp. and to
expand the colonic Treg pool [52–54] mediate the effect on
the adaptive immune system.
While this study illustrates the profound effect of intestinal
microbes on susceptibility to food allergy, induction of immune
regulation can also impact the microbiota. Mice that are highly
susceptible to food allergy due to a gain-of-functionmutation in
the IL-4 receptor alpha chain (IL4ra709 mice) displayed altered
intestinal microbial profiles following oral allergic sensitization
compared to sensitized control animals [55]. Of note, transfer
of allergen-specific Treg not only suppressed allergic sensitiza-
tion and allergen induced anaphylaxis, but also protected from
development of microbial dysbiosis [55], providing evidence for
host-microbial cross-talk in allergic sensitization.8. Concluding remarks
Colonization with a diverse microbiota early in life appears to
be critical for instructing regulation on the developing immune
system. Failure to achieve a certain level of diversity, or
absence of keymicrobial constituents, during a critical window
of opportunity early in life leads to a dysregulated immune
system similar to what is found in germ-free mice. Further
understanding of the mechanisms by which microbes educate
the immune system during early life and how this impacts
on development of allergic disease will be key for rationale
design ofmicrobiota-based therapies for preventive treatment
regimes.Conflict of interest statement
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